GLP-1 Medication Use Has Become Commonplace
As celebrity discussions highlight widespread adoption, learn what you should consider about these treatments.
Updated on Sept. 24, 2026 in Weight Loss
Recent on-air conversations among television hosts have highlighted the growing prevalence of GLP-1 weight loss medications. Currently, one in 10 adults in the United States uses these drugs.
Why it matters
The increased public discourse reflects the broad integration of these medications into American life, marking a shift in how weight management is discussed. Understanding the population-level impact of these treatments is essential for patients navigating their own health options.
Nationwide population data indicates that one in 10 adults currently uses GLP-1 medication. While this reflects significant uptake, the long-term clinical outcomes across the entire patient population remain under study.
The players
Al Roker
A television personality and advocate for metabolic health who underwent gastric bypass surgery in 2002.
Craig Melvin
A television host and journalist who confirmed his weight loss during a recent broadcast.
Dylan Dreyer
A television meteorologist and host who publicly inquired about the prevalence of weight loss medication usage.
The details
GLP-1 receptor agonists function by mimicking hormones that signal satiety to the brain and slow stomach emptying. These medications have gained significant attention for their role in managing weight and metabolic health, often becoming a focal point in broader discussions about nutrition and diet. As awareness grows, clinical conversations often center on balancing medication with dietary protein intake, such as the 20 grams found in items like a Sausage Egg McMuffin.
Timeline
Al Roker underwent gastric bypass surgery in 2002.
Jenna Bush Hager addressed her GLP-1 usage status in September 2025.
Dylan Dreyer asked Craig Melvin about his medication usage on September 24, 2026.
Health Landscape
The clinical adoption of GLP-1 agonists represents a significant evolution in obesity medicine, moving from specialized intervention to a mainstream health trend. This shift tracks alongside long-standing surgical options, such as the gastric bypass procedures practiced for decades.
Given the rising use of these medications, it is important to have an open conversation with your doctor about whether these treatments are appropriate for your specific health history. Focus your discussion on long-term goals rather than short-term trends to ensure your plan is evidence-based.
The takeaway
Weight management medication has become a common topic in both personal and professional settings, reflecting the one-in-10 adoption rate among U.S. adults. Always consult with a licensed physician to evaluate if pharmacological weight management aligns with your personal health and metabolic profile.
Further reading
For more information on the current landscape of clinical treatments, visit Weight Loss.
